These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26851988)

  • 21. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
    Ji J; Sharma V; Qi S; Guarch ME; Zhao P; Luo Z; Fan W; Wang Y; Mbabaali F; Neculai D; Esteban MA; McPherson JD; Batada NN
    Stem Cell Reports; 2014 Jan; 2(1):44-51. PubMed ID: 24511469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.
    Quinlan AR; Boland MJ; Leibowitz ML; Shumilina S; Pehrson SM; Baldwin KK; Hall IM
    Cell Stem Cell; 2011 Oct; 9(4):366-73. PubMed ID: 21982236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the Production and Application of Induced Pluripotent Stem Cells.
    Mortada I; Bilani N
    Curr Stem Cell Res Ther; 2017; 12(8):637-643. PubMed ID: 28969537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome stability of programmed stem cell products.
    Martin U
    Adv Drug Deliv Rev; 2017 Oct; 120():108-117. PubMed ID: 28917518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences.
    Hussein SM; Elbaz J; Nagy AA
    Bioessays; 2013 Mar; 35(3):152-62. PubMed ID: 23172728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells.
    Tidball AM; Neely MD; Chamberlin R; Aboud AA; Kumar KK; Han B; Bryan MR; Aschner M; Ess KC; Bowman AB
    PLoS One; 2016; 11(3):e0150372. PubMed ID: 26982737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.
    Lu J; Li H; Hu M; Sasaki T; Baccei A; Gilbert DM; Liu JS; Collins JJ; Lerou PH
    Cell Rep; 2014 Apr; 7(1):70-8. PubMed ID: 24685138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research.
    Cheng H; Liu C; Cai X; Lu Y; Xu Y; Yu X
    Curr Stem Cell Res Ther; 2016; 11(5):444-50. PubMed ID: 26899393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Basal Levels of γH2AX in Human Induced Pluripotent Stem Cells Are Linked to Replication-Associated DNA Damage and Repair.
    Vallabhaneni H; Lynch PJ; Chen G; Park K; Liu Y; Goehe R; Mallon BS; Boehm M; Hursh DA
    Stem Cells; 2018 Oct; 36(10):1501-1513. PubMed ID: 29873142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells.
    Phanthong P; Raveh-Amit H; Li T; Kitiyanant Y; Dinnyes A
    Biogerontology; 2013 Dec; 14(6):591-602. PubMed ID: 23963527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.